Dr Hamied’s leadership gift endows both a fund to attract and support the world’s brightest academic talent in chemistry, including exceptional early career researchers in disciplines such as synthetic organic chemistry, and outstanding doctoral students from the UK and around the world through the new Hamied Scholars Programme.
For much of his life, Dr Hamied has been a leader in industry and philanthropy, focusing his attention on education and healthcare. He is currently the non-executive chairman of Cipla, a global pharmaceutical company started by his late father, Dr K A Hamied, in Mumbai. Yusuf Hamied’s major achievements include the pioneering supply of HIV/AIDS medicines to developing countries at a low cost, saving countless lives. To help patients during the COVID-19 pandemic, Cipla is again providing medicines to healthcare organisations at affordable prices, making treatment more accessible.
The Vice-Chancellor, Professor Stephen J Toope said: “Yusuf Hamied has demonstrated an unequivocal commitment to changing and improving lives since his time at Cambridge. I am profoundly grateful for his remarkable gift to the Department of Chemistry, which will benefit generations of students and researchers.”
Reproduced courtesy of the University of Cambridge